0

Journal Articles

in Thromboembolism/Anticoagulation
 81-100 of 149 Articles
Editorial |  February 09, 2005
Ximelagatran—Promises and Concerns
Victor Gurewich, MD
JAMA. 2005;293(6):736-739. doi:10.1001/jama.293.6.736.
Original Contribution |  February 09, 2005 FREE
Ximelagatran vs Warfarin for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation:  A Randomized Trial
JAMA. 2005;293(6):690-698. doi:10.1001/jama.293.6.690.
Original Contribution |  February 09, 2005 FREE
Costs and Effectiveness of Ximelagatran for Stroke Prophylaxis in Chronic Atrial Fibrillation
Cara L. O’Brien, MD; Brian F. Gage, MD, MSc
JAMA. 2005;293(6):699-706. doi:10.1001/jama.293.6.699.
Original Contribution |  February 09, 2005 FREE
Ximelagatran vs Low-Molecular-Weight Heparin and Warfarin for the Treatment of Deep Vein Thrombosis:  A Randomized Trial
Jean-Noel Fiessinger, MD; Menno V. Huisman, MD; Bruce L. Davidson, MD; et al.
JAMA. 2005;293(6):681-689. doi:10.1001/jama.293.6.681.
Original Contribution |  February 02, 2005 FREE
Patterns of Care for Adults With Newly Diagnosed Malignant Glioma
Susan M. Chang, MD; Ian F. Parney, MD, PhD; Wei Huang, MS; et al.
JAMA. 2005;293(5):557-564. doi:10.1001/jama.293.5.557.
Original Contribution |  January 26, 2005 FREE
Effects of Reviparin, a Low-Molecular-Weight Heparin, on Mortality, Reinfarction, and Strokes in Patients With Acute Myocardial Infarction Presenting With ST-Segment Elevation
The CREATE Trial Group Investigators*
JAMA. 2005;293(4):427-435. doi:10.1001/jama.293.4.427.
Brief Report |  October 20, 2004 FREE
Long-term Outcome After Intravenous Thrombolysis of Basilar Artery Occlusion
Perttu J. Lindsberg, MD, PhD; Lauri Soinne, MD; Turgut Tatlisumak, MD, PhD; et al.
JAMA. 2004;292(15):1862-1866. doi:10.1001/jama.292.15.1862.
Original Contribution |  October 20, 2004 FREE
Predictors of In-Hospital Mortality in Patients With Acute Ischemic Stroke Treated With Thrombolytic Therapy
Peter U. Heuschmann, MD, MPH; Peter L. Kolominsky-Rabas, MD; Joachim Roether, MD; et al.
JAMA. 2004;292(15):1831-1838. doi:10.1001/jama.292.15.1831.
Original Contribution |  October 20, 2004 FREE
Lack of Improvement in Patients With Acute Stroke After Treatment With Thrombolytic Therapy:  Predictors and Association With Outcome
Gustavo Saposnik, MD; Bryan Young, MD; Brian Silver, MD; et al.
JAMA. 2004;292(15):1839-1844. doi:10.1001/jama.292.15.1839.
Editorial |  October 06, 2004
Measuring Race and Ethnicity: Why and How?
Margaret A. Winker, MD
JAMA. 2004;292(13):1612-1614. doi:10.1001/jama.292.13.1612.
Medical News and Perspectives |  August 11, 2004
Study Reveals Ginseng Supplements May Hamper Effects of Anticlotting Drug
JAMA. 2004;292(6):674. doi:10.1001/jama.292.6.674.
Original Contribution |  August 11, 2004 FREE
Long-term Efficacy of Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade vs Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Revascularization:  REPLACE-2 Randomized Trial
A. Michael Lincoff, MD; Neal S. Kleiman, MD; Dean J. Kereiakes, MD; et al.
JAMA. 2004;292(6):696-703. doi:10.1001/jama.292.6.696.
Editorial |  July 07, 2004
Fractionating Heparins and Their Clinical Trial Data—Something for Everyone
Pranab Das, MD; David J. Moliterno, MD
JAMA. 2004;292(1):101-103. doi:10.1001/jama.292.1.101.
Original Contribution |  July 07, 2004 FREE
Safety and Efficacy of Enoxaparin vs Unfractionated Heparin in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Who Receive Tirofiban and Aspirin:  A Randomized Controlled Trial
Michael A. Blazing, MD; James A. de Lemos, MD; Harvey D. White, MD; et al.
JAMA. 2004;292(1):55-64. doi:10.1001/jama.292.1.55.
Original Contribution |  July 07, 2004 FREE
Enoxaparin vs Unfractionated Heparin in High-Risk Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Managed With an Intended Early Invasive Strategy:  Primary Results of the SYNERGY Randomized Trial
JAMA. 2004;292(1):45-54. doi:10.1001/jama.292.1.45.
Review |  July 07, 2004 FREE
Efficacy and Bleeding Complications Among Patients Randomized to Enoxaparin or Unfractionated Heparin for Antithrombin Therapy in Non–ST-Segment Elevation Acute Coronary Syndromes:  A Systematic Overview
John L. Petersen, MD; Kenneth W. Mahaffey, MD; Vic Hasselblad, PhD; et al.
JAMA. 2004;292(1):89-96. doi:10.1001/jama.292.1.89.
Original Contribution |  February 04, 2004 FREE
Antiphospholipid Antibodies and Subsequent Thrombo-occlusive Events in Patients With Ischemic Stroke
JAMA. 2004;291(5):576-584. doi:10.1001/jama.291.5.576.
JAMA Patient Page |  December 03, 2003 FREE
Pulmonary Embolism
Sharon Parmet, MS; Cassio Lynm, MA; Richard M. Glass, MD
JAMA. 2003;290(21):2898. doi:10.1001/jama.290.21.2779.
The Rational Clinical Examination |  December 03, 2003
Does This Patient Have Pulmonary Embolism?
Sanjeev D. Chunilal, MB, ChB, FRACP, FRCPA; John W. Eikelboom, MBBS, MSc, FRACP, FRCPA; John Attia, MD, PhD, FRCPC; et al.
JAMA. 2003;290(21):2849-2858. doi:10.1001/jama.290.21.2849.
INCLUDES: CME
Original Contribution |  November 26, 2003 FREE
Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation:  How Well Do Randomized Trials Translate Into Clinical Practice?
Alan S. Go, MD; Elaine M. Hylek, MD, MPH; Yuchiao Chang, PhD; et al.
JAMA. 2003;290(20):2685-2692. doi:10.1001/jama.290.20.2685.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Original Investigation  |  April 1, 2013
Use of Glucocorticoids and Risk of Venous Thromboembolism:  A Nationwide Population-Based Case-Control Study
Sigrun A. Johannesdottir, BSc; Erzsébet Horváth-Puhó, MSc, PhD; Olaf M. Dekkers, MD, PhD, MSc, MA; et al.
JAMA Internal Medicine
Editor's Correspondence  |  May 13, 2013
Resumption of Warfarin Therapy After Gastrointestinal Tract Bleeding: Benefit or Bias?
Kristian B. Filion, PhD; Jonathan Assayag, MSc; Laurent Azoulay, PhD
JAMA Internal Medicine
Editor's Correspondence  |  May 13, 2013
Resumption of Warfarin Therapy After Gastrointestinal Tract Bleeding: Benefit or Bias?—Reply
Daniel M. Witt, PharmD; Thomas Delate, PhD; Mark A. Crowther, MD
JAMA Internal Medicine
Editor's Correspondence  |  May 13, 2013
New Oral Anticoagulants in Acute Coronary Syndromes: What Does a Meta-analysis Tell Us?
Joey S. W. Kwong, PhD; Cheuk-Man Yu, MD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems